Maximus (MMS) Receives News Impact Score of 0.11

News coverage about Maximus (NYSE:MMS) has trended somewhat positive on Tuesday, Accern reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Maximus earned a coverage optimism score of 0.11 on Accern’s scale. Accern also assigned press coverage about the health services provider an impact score of 44.3365399360587 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the news articles that may have effected Accern Sentiment Analysis’s scoring:

Shares of Maximus (NYSE MMS) opened at 65.35 on Tuesday. Maximus has a 52-week low of $43.69 and a 52-week high of $65.87. The company has a market capitalization of $4.24 billion, a PE ratio of 20.95 and a beta of 1.36. The stock’s 50 day moving average price is $62.58 and its 200-day moving average price is $61.86.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The company’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.79 EPS. On average, analysts expect that Maximus will post $3.13 earnings per share for the current year.

A number of analysts have recently issued reports on MMS shares. Zacks Investment Research upgraded Maximus from a “hold” rating to a “buy” rating and set a $73.00 price objective on the stock in a research report on Wednesday, October 4th. Robert W. Baird started coverage on Maximus in a research report on Sunday, September 3rd. They set a “neutral” rating on the stock. BidaskClub cut Maximus from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 6th. Maxim Group set a $66.00 price objective on Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. Finally, Canaccord Genuity cut Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a research report on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $63.14.

ILLEGAL ACTIVITY WARNING: This story was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://ledgergazette.com/2017/10/10/maximus-mms-receives-news-impact-score-of-0-11.html.

In other Maximus news, Director Paul R. Lederer sold 2,200 shares of Maximus stock in a transaction on Monday, August 14th. The stock was sold at an average price of $60.87, for a total value of $133,914.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Richard A. Montoni sold 29,203 shares of Maximus stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total value of $1,763,277.14. Following the completion of the transaction, the chief executive officer now directly owns 549,215 shares of the company’s stock, valued at $33,161,601.70. The disclosure for this sale can be found here. Insiders sold a total of 160,403 shares of company stock valued at $9,912,181 over the last ninety days. Insiders own 3.10% of the company’s stock.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply